Skip to content

Color Synbiotics Study

Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Synbiotics Mixtures on Gut Microbiota Composition in Healthy Infants.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01813175
Enrollment
290
Registered
2013-03-18
Start date
2013-05-31
Completion date
2016-07-31
Last updated
2017-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beneficial Bacteria in Gut

Brief summary

This study is initiated to investigate the effect of infant formula with added specific synbiotics mixture on proportion of beneficial bacteria.

Interventions

OTHERRegular non-hydrolysed cow's milk I

Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture I

OTHERRegular non-hydrolysed cow's milk II

Regular non-hydrolysed cow's milk based infant formula with synbiotics mixture II

OTHERRegular non-hydrolysed cow's milk - control

Regular non-hydrolysed cow's milk based infant formula without synbiotics mixture

Sponsors

Danone Asia Pacific Holdings Pte, Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
43 Days to 65 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy term infants (gestational age ≥ 37 1/7 and ≤ 41 6/7 weeks) aged 46 - 65 days (inclusive) at entry into the study * Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study) * Parents' or legal guardian's written informed consent

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frame
Change of Baseline proportion of beneficial bacteria at week 6 in interventional group compared to the change in control groupbaseline, week 6

Secondary

MeasureTime frame
Change of proportion of baseline beneficial bacteria at week 6 in interventional group I compared to the change in control groupbaseline, week 6
Change of Baseline proportion of beneficial bacteria at week 6 in interventional group II compared to the change in control groupbaseline, week 6

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026